BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

506128

PARNAXLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PARNAX LAB LTD. Share Price Update

As of the latest trading session, PARNAX LAB LTD. share price is currently at ₹ 92.5, which is down by ₹ -1.84 from its previous closing. Today, the stock has fluctuated between ₹ 92.50 and ₹ 94.35. Over the past year, PARNAX LAB LTD. has achieved a return of -26.26 %. In the last month alone, the return has been -11.82 %. Read More...

PARNAX LAB LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    106.24

  • P/E Ratio (TTM)

    64.24

  • Beta

    0.88

  • Book Value / share

    19.56

  • Return on equity

    6.54%

  • EPS (TTM)

    1.44

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.16

info icon alternate text

PARNAX LAB LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.99
Operating Expense 0.95
Net Profit 0.16
Net Profit Margin (%) 16.16
Earnings Per Share (EPS) 0.14
EBITDA 0.24
Effective Tax Rate (%) 23.80
Particulars SEP 2024 (Values in Cr)
Revenue 1.54
Operating Expense 1.35
Net Profit 0.27
Net Profit Margin (%) 17.53
Earnings Per Share (EPS) 0.24
EBITDA 0.38
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 3.66
Operating Expense 2.42
Net Profit 1.05
Net Profit Margin (%) 28.68
Earnings Per Share (EPS) 0.91
EBITDA 1.43
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 1.71
Operating Expense 1.58
Net Profit 0.17
Net Profit Margin (%) 9.94
Earnings Per Share (EPS) 0.15
EBITDA 0.27
Effective Tax Rate (%) 29.16
Particulars DEC 2023 (Values in Cr)
Revenue 2.77
Operating Expense 1.56
Net Profit 0.99
Net Profit Margin (%) 35.74
Earnings Per Share (EPS) 0.86
EBITDA 1.35
Effective Tax Rate (%) 25.56
Particulars MAR 2024 (Values in Cr)
Revenue 7.44
Operating Expense 5.52
Net Profit 1.82
Net Profit Margin (%) 24.46
Earnings Per Share (EPS) 1.59
EBITDA 2.65
Effective Tax Rate (%) 25.30
Particulars MAR 2023 (Values in Cr)
Revenue 7.47
Operating Expense 6.22
Net Profit 1.20
Net Profit Margin (%) 16.06
Earnings Per Share (EPS) 1.09
EBITDA 1.95
Effective Tax Rate (%) 25.76
Particulars MAR 2022 (Values in Cr)
Revenue 7.15
Operating Expense 6.54
Net Profit 0.54
Net Profit Margin (%) 7.55
Earnings Per Share (EPS) 0.64
EBITDA 1.53
Effective Tax Rate (%) 30.76
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 3.69
Net Profit -1.13
Net Profit Margin (%) -47.67
Earnings Per Share (EPS) -1.33
EBITDA -0.38
Effective Tax Rate (%) 9.60
Particulars MAR 2020 (Values in Cr)
Revenue 7.68
Operating Expense 8.57
Net Profit -2.00
Net Profit Margin (%) -26.04
Earnings Per Share (EPS) -2.36
EBITDA 0.95
Effective Tax Rate (%) -325.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 62.32
ROE % 14.39
ROCE % 12.87
Total Debt to Total Equity 1.01
EBITDA Margin 12.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.11
ROE % 15.64
ROCE % 14.66
Total Debt to Total Equity 1.12
EBITDA Margin 14.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.24
ROE % 20.47
ROCE % 16.71
Total Debt to Total Equity 1.59
EBITDA Margin 14.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.26
ROE % -1.13
ROCE % 5.67
Total Debt to Total Equity 1.69
EBITDA Margin 11.27
Particulars MAR 2020 (Values in Cr)
Book Value / Share 38.56
ROE % -8.52
ROCE % 3.24
Total Debt to Total Equity 1.36
EBITDA Margin 7.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.42
ROE % 6.54
ROCE % 9.09
Total Debt to Total Equity 0.03
EBITDA Margin 35.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 16.85
ROE % 4.77
ROCE % 6.18
Total Debt to Total Equity 0.32
EBITDA Margin 25.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.14
ROE % 3.98
ROCE % 6.24
Total Debt to Total Equity 1.18
EBITDA Margin 21.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.13
EBITDA Margin -16.03
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.85
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.63
EBITDA Margin 12.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 188.76
Total Liabilities 188.76
Total Equity 71.69
Share Outstanding 11485616
Price to Book Ratio 7.03
Return on Assets (%) 5.09
Return on Capital (%) 6.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.78
Total Assets 145.07
Total Liabilities 145.07
Total Equity 62.26
Share Outstanding 11485616
Price to Book Ratio 3.09
Return on Assets (%) 5.94
Return on Capital (%) 7.62
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.78
Total Assets 153.46
Total Liabilities 153.46
Total Equity 48.27
Share Outstanding 9814866
Price to Book Ratio 11.82
Return on Assets (%) 5.37
Return on Capital (%) 7.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.26
Total Assets 106.25
Total Liabilities 106.25
Total Equity 32.62
Share Outstanding 8504866
Price to Book Ratio 3.52
Return on Assets (%) -0.34
Return on Capital (%) -0.41
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 107.15
Total Liabilities 107.15
Total Equity 32.86
Share Outstanding 8504866
Price to Book Ratio 1.77
Return on Assets (%) -2.71
Return on Capital (%) -3.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 22.23
Total Liabilities 22.23
Total Equity 21.15
Share Outstanding 11485616
Price to Book Ratio 7.03
Return on Assets (%) 8.20
Return on Capital (%) 8.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.36
Total Liabilities 21.36
Total Equity 19.35
Share Outstanding 11485616
Price to Book Ratio 3.09
Return on Assets (%) 5.63
Return on Capital (%) 5.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.34
Total Assets 23.53
Total Liabilities 23.53
Total Equity 12.74
Share Outstanding 9814866
Price to Book Ratio 11.82
Return on Assets (%) 2.30
Return on Capital (%) 2.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 17.64
Total Liabilities 17.64
Total Equity 4.71
Share Outstanding 8504866
Price to Book Ratio 3.52
Return on Assets (%) -6.41
Return on Capital (%) -7.02
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 18.65
Total Liabilities 18.65
Total Equity 5.82
Share Outstanding 8504866
Price to Book Ratio 1.77
Return on Assets (%) -10.74
Return on Capital (%) -12.06
Particulars MAR 2024 (Values in Cr)
Net Income 12.04
Cash from Operations 18.51
Cash from Investing -31.51
Cash from Financing 14.81
Net change in Cash -0.82
Free Cash Flow 32.65
Particulars MAR 2023 (Values in Cr)
Net Income 12.27
Cash from Operations 23.77
Cash from Investing -9.92
Cash from Financing -14.06
Net change in Cash -3.08
Free Cash Flow 35.05
Particulars MAR 2022 (Values in Cr)
Net Income 12.26
Cash from Operations 8.78
Cash from Investing -16.49
Cash from Financing 12.13
Net change in Cash 4.18
Free Cash Flow 26.61
Particulars MAR 2021 (Values in Cr)
Net Income -0.08
Cash from Operations 7.06
Cash from Investing -6.56
Cash from Financing 0.05
Net change in Cash -0.20
Free Cash Flow 11.61
Particulars MAR 2020 (Values in Cr)
Net Income -1.96
Cash from Operations 9.81
Cash from Investing -13.33
Cash from Financing 5.02
Net change in Cash 0.43
Free Cash Flow 22.99
Particulars MAR 2024 (Values in Cr)
Net Income 2.44
Cash from Operations 0.09
Cash from Investing 0.30
Cash from Financing -1.21
Net change in Cash -0.82
Free Cash Flow 0.21
Particulars MAR 2023 (Values in Cr)
Net Income 1.62
Cash from Operations -0.26
Cash from Investing 0.13
Cash from Financing -2.92
Net change in Cash -3.06
Free Cash Flow -0.21
Particulars MAR 2022 (Values in Cr)
Net Income 0.77
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 4.59
Net change in Cash 4.23
Free Cash Flow -0.35
Particulars MAR 2021 (Values in Cr)
Net Income -1.25
Cash from Operations 0.47
Cash from Investing 0.00
Cash from Financing -0.47
Net change in Cash 0.00
Free Cash Flow 0.47
Particulars MAR 2020 (Values in Cr)
Net Income -0.47
Cash from Operations 2.18
Cash from Investing -0.01
Cash from Financing -1.54
Net change in Cash 0.63
Free Cash Flow 2.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

PARNAX LAB LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
92.50 -1.96 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 96.00
  • 26 Days 100.50
  • 10 Days 98.30
  • 50 Days 106.10
  • 12 Days 98.80
  • 100 Days 116.60
  • 20 Days 99.80
  • 200 Days 120.40
94.38 PIVOT

First Support

94.32

First Resistance

94.42

Second Support

94.28

Second Resistance

94.48

Third Support

94.22

Third Resistance

94.52

RSI

34.57

ADX

27.31

MACD

-1.74

Williams % R

-100.00

Commodity Channel Index (CCI)

-187.59

Date

2025-04-30

Week

1805.00

Same Day

1334.00

Month

1465.00

1 Year

0.89

3 Year

0.80

Over 1 Month

-11.82%

down

Over 1 Year

-26.26%

down

Over 3 Months

-35.58%

down

Over 3 Years

-10.71%

down

Over 6 Months

-36.11%

down

Over 5 Years

36.65%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

PARNAX LAB LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
27.7%
Promoter Holdings
72.29%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
9.41%
Name Shares Category
Binoy Baiju Shah 1369600.0 (11.92%) Shareholding of Promoter and Promoter Group
Ila B Shah 1361872.0 (11.86%) Shareholding of Promoter and Promoter Group
Baiju Mahasukhlal Shah 1329261.0 (11.57%) Shareholding of Promoter and Promoter Group
Prakash Mahasukhlal Shah 1201676.0 (10.46%) Shareholding of Promoter and Promoter Group
Mihir Prakash Shah 1141250.0 (9.94%) Shareholding of Promoter and Promoter Group
Pragna Prakash Shah 1066137.0 (9.28%) Shareholding of Promoter and Promoter Group
Ami Mihir Shah 833970.0 (7.26%) Shareholding of Promoter and Promoter Group
Suman Gupta 186000.0 (1.62%) Public Shareholding

News

Left Arrow
Right Arrow

PARNAX LAB LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PARNAX LAB LTD. Share Price

Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities.

Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar's prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in
Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh.

Naxpar's key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.

Parent organization Indian Private
NSE symbol [-]
Founded 1982
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Parnax Lab Ltd?

Answer Field

The share price of Parnax Lab Ltd for NSE is ₹ 0.00 and for BSE is ₹ 92.50.

What is the Market Cap of Parnax Lab Ltd?

Answer Field

The market cap of Parnax Lab Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,06.20 Cr. as of now.

What is the 52 Week High and Low of Parnax Lab Ltd?

Answer Field

The 52 Week High and Low of Parnax Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 193.50 and ₹ 81.00.

How to Buy Parnax Lab Ltd share?

Answer Field

You can trade in Parnax Lab Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Parnax Lab Ltd?

Answer Field

The 1 year returns on the stock has been -26.26%.

What is the Current Share Price of Parnax Lab Ltd?

Answer Field

Parnax Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 92.50 as on Apr 30 2025 03:15 PM.

What is the Market Cap of Parnax Lab Ltd Share?

Answer Field

The market cap of Parnax Lab Ltd for NSE ₹ 0.0 & for BSE ₹ 1,06.20 as on Apr 30 2025 03:15 PM.

What is the P/E Ratio of Parnax Lab Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM the price-to-earnings (PE) ratio for Parnax Lab Ltd share is 64.24.

What is the PB ratio of Parnax Lab Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM, the price-to-book (PB) ratio for Parnax Lab Ltd share is 19.56.

How to Buy Parnax Lab Ltd Share?

Answer Field

You can trade in Parnax Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parnax Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Parnax Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parnax Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|